Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis
- PMID: 33718796
- PMCID: PMC7930779
- DOI: 10.1016/j.mayocpiqo.2020.08.003
Timed Controlled Repeated Rotation of the CAR-170-C NXSTAGE Chronic Cartridge Hemodialysis Filter: A Novel Approach to Enabling Heparin-Free Frequent Daily Home Hemodialysis
Abstract
Heparin-free hemodialysis is often warranted in postoperative states, bleeding diathesis, and critically ill patients. Conventionally, this is achieved through normal saline flushes or regional citrate anticoagulation. An 87-year-old white man with end-stage renal disease and atrial fibrillation, who was taking warfarin and using maintenance home hemodialysis (HHD) with an NxStage machine, underwent laparoscopic appendicectomy. The procedure was complicated by intra-abdominal abscess, sepsis, and tamponade from a bloody pericardial effusion. He needed emergent therapeutic pericardiocentesis. Warfarin was promptly discontinued. He was discharged home with heparin-free HHD. Prior heparin anticoagulation for HHD was an initial bolus of 4000 units of heparin. He continued to clot his extracorporeal system with resultant very high venous pressures and compromised HHD. Heparin anticoagulation was still contraindicated. Flushes with 250-500 mL normal saline, delivered in aliquots every 15-30 minutes, failed to prevent the frequent clotting. The first author, our HD Senior Technician, had astutely observed that the horizontally placed hemodialysis filter exhibited early "clot" formation at the 12-o'clock position, despite the saline flushes. Through trial and error, he discovered that rotating the horizontally placed hemodialysis filter along its long axis, 60 degrees clockwise for 15 minutes, return to the neutral position for 15 minutes, rotating the filter another 60 degrees counterclockwise for 15 minutes, with this repeated cycle of rotations "did the trick." It promptly and consistently resolved the clotting problem. The lines stopped clotting, and he has not needed saline flushes for smooth heparin-free HHD for more than 7 months. To our knowledge, this is the first such report. Further study is justified. We have hypothesized a mechanism and have named this the "Locke-Onuigbo Maneuver."
Keywords: ECMO, extracorporeal membrane oxygenation; HHD, home hemodialysis.
© 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.
Figures


Similar articles
-
Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.Am J Nephrol. 2002 Jan-Feb;22(1):58-66. doi: 10.1159/000046675. Am J Nephrol. 2002. PMID: 11919404 Clinical Trial.
-
Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.Ther Apher Dial. 2013 Apr;17(2):202-12. doi: 10.1111/j.1744-9987.2012.01101.x. Epub 2012 Aug 29. Ther Apher Dial. 2013. PMID: 23551677
-
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23. Am J Kidney Dis. 2016. PMID: 27344212 Clinical Trial.
-
Intensive Home Hemodialysis: An Eye at the Past Looking for the Hemodialysis of the Future.Artif Organs. 2015 Sep;39(9):736-40. doi: 10.1111/aor.12458. Epub 2015 Apr 29. Artif Organs. 2015. PMID: 25920990 Review.
-
[Anticoagulation of the extracorporeal circuit in chronic hemodialysis].Nephrologie. 1998;19(4):223-5. Nephrologie. 1998. PMID: 9675763 Review. French.
References
-
- Saltisi D. In: Dialysis Therapy. 3rd ed. Nissenson A.R., Fine R.D., editors. Hanley and Belfus; Philadelphia: 2002. Management of anticoagulation for hemodialysis; pp. 82–86.
-
- Miklaszewska M., Korohoda P., Zachwieja K., et al. Filter size not the anticoagulation method is the decisive factor in continuous renal replacement therapy circuit survival. Kidney Blood Press Res. 2017;42(2):327–337. - PubMed
-
- Stegmayr B.G., Jonsson P., Mahmood D. A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation. Int J Artif Organs. 2013;36(1):1–6. - PubMed
-
- Rossignol P., Dorval M., Fay R., et al. Rationale and design of the HepZero study: A prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: Study protocol for a randomized controlled trial. Trials. 2013;14:163. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources